Article
Clinical utility of direct mutation testing for congenital nephrogenic diabetes insipidus in families.
Pediatrics - 1 Mar 1999
Wildin R S, Cogdell D E
Abstract excerpt
OBJECTIVE: To ascertain the clinical scenarios in which genetic testing for congenital nephrogenic diabetes insipidus (NDI) by direct detection of mutations might prove valuable, and to assess the use of automated sequencing for testing. METHODS: We reviewed NDI cases referred to our research laboratory for enrollment in our study of mutations in the AVPR2 gene that is disrupted in the X-linked form of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
